Document Detail


Pharmacological Characterization and Modeling of the Binding Sites of Novel 1,3-bis(pyridinylethynyl)benzenes as Metabotropic Glutamate Receptor 5-selective Negative Allosteric Modulators.
MedLine Citation:
PMID:  22899869     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Metabotropic glutamate receptor subtype 5 (mGluR5) is a potential drug target in neurological and psychiatric disorders, and subtype-selective allosteric modulators have attracted much attention as potential drug candidates. In this study the binding sites of three novel MPEP-derived negative allosteric modulators, 2-, 3- and 4-BisPEB, have been characterized. 2-, 3-, and 4-BisPEB are 1,3-bis(pyridinylethynyl)-benzenes and differ only by the position of the nitrogen atom in the pyridine rings. Despite their high structural similarity, 2-BisPEB (1,3-bis(pyridin-2-ylethynyl)-benzene, nitrogen atom in ortho position), with an IC(50)-value in the nanomolar range, is significantly more potent than the 3- and 4-pyridyl analogues. Mutational analysis, directed by a previously published mGluR5 homology model, was used to determine key residues for the ligand-receptor interactions that may explain the potency differences of 2-, 3-, and 4-BisPEB. Residues I651, P655, Y659, N747, W785, F788, Y792, S809, and A810 were found to have critical roles for the activity of one or more of the three BisPEBs and the reference compound MPEP. The mutational data suggest that the higher potency of 2-BisPEB is due to hydrogen bonding to S809 as the S809A mutation made 2-BisPEB equipotent to 3- and 4-BisPEB (IC(50): 1-2.5 μM). The potency of MPEP was also greatly affected by S809A (52-fold) suggesting that a S809-mediated hydrogen bond is also a key interaction between MPEP and mGluR5. Potential binding modes of 2-, 3- and 4- BisPEB obtained by molecular docking to the mGluR5 homology model provides a structural context for the reported major mutational effects.
Authors:
Christina Molck; Kasper Harpsoe; David E Gloriam; Rasmus P Clausen; Ulf Madsen; Lars O Pedersen; Hermogenes N Jimenez; Soren M Nielsen; Jesper M Mathiesen; Hans Brauner-Osborne
Related Documents :
22722609 - Shape-dependent electrocatalysis: formic acid electrooxidation on cubic pd nanoparticles.
22905009 - 1,2-bis[(3,5-diphenyl-1h-pyrazol-1-yl)meth-yl]benzene.
22673899 - Unusual cos(2) ellipsoids with anisotropic tube-like cavities and their application in ...
15789569 - Microwave assisted imdaf# reaction: microwave irradiation applied with success to cyclo...
18211089 - Predictions of substituent effects in thermal azide 1,3-dipolar cycloadditions: implica...
22367979 - Nitrogen-rich 5,5'-bistetrazolates and their potential use in propellant systems: a com...
15878449 - Mass spectrometric decompositions of cationized beta-cyclodextrin.
17081009 - Tunable capsule space: self-assembly of hemispherical cavitands with hydrogen-bonding l...
18519199 - Enhancement of q(m) by co-doping of li and cu to potassium sodium niobate lead-free cer...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-16
Journal Detail:
Title:  Molecular pharmacology     Volume:  -     ISSN:  1521-0111     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 University of Copenhagen;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that se...
Next Document:  Resistant hypertension and the neglected antihypertensive: sodium restriction.